Validating the European randomised study for screening of prostate cancer (ERSPC) risk calculator in a contemporary South African cohort

ConclusionOur results confirm the validity of the ERSPC RC in a South African cohort. Application of this calculator to the wider South African population would allow better selection of patients for prostate biopsy and spare a significant number its adverse consequences.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research